Neurocrine Biosciences (NBIX) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $152.72 +1.26%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of ($0.22), $0.07 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $15 million versus the consensus estimate of $15.43 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- Neurocrine's Ingrezza study shows quality-of-life gains in TD patients
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
